Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Brief interventions and referral for smoking cessation in primary care and other settings.

BIBLIOGRAPHIC SOURCE(S)

  • National Institute for Health and Clinical Excellence (NICE). Brief interventions and referral for smoking cessation in primary care and other settings. London (UK): National Institute for Health and Clinical Excellence (NICE); 2006 Mar. 36 p. (Public health intervention; no. 1).

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

1.1 Brief Interventions in Health and Community Care

Brief interventions involve opportunistic advice, discussion, negotiation, or encouragement. They are commonly used in many areas of health promotion and are delivered by a range of primary and community care professionals.

For smoking cessation, brief interventions typically take between 5 and 10 minutes and may include one or more of the following:

  • Simple opportunistic advice to stop
  • An assessment of the patient's commitment to quit
  • An offer of pharmacotherapy and/or behavioural support
  • Provision of self-help material and referral to more intensive support such as the National Health Service (NHS) Stop Smoking Services.

The particular package that is provided will depend on a number of factors, including the individual's willingness to quit, how acceptable they find the intervention on offer and the previous ways they have tried to quit. See Diagram 1 in the original Guideline Document for a summary of this care pathway.

1.1.1 Practice Recommendations

Who Should Receive Advice?

Recommendation 1: Everyone who smokes should be advised to quit, unless there are exceptional circumstances*. People who are not ready to quit should be asked to consider the possibility and encouraged to seek help in the future. If an individual who smokes presents with a smoking-related disease, the cessation advice may be linked to their medical condition.

Recommendation 2: People who smoke should be asked how interested they are in quitting*. Advice to stop smoking should be sensitive to the individual's preferences, needs and circumstances: there is no evidence that the "stages of change" model** is more effective than any other approach.

Who should advise smokers and how?

Recommendation 3: General practitioners (GPs) should take the opportunity to advise all patients* who smoke to quit when they attend a consultation. Those who want to stop should be offered a referral to an intensive support service (for example, NHS Stop Smoking Services). If they are unwilling or unable to accept this referral they should be offered pharmacotherapy in line with National Institute for Health and Clinical Excellence (NICE) technology appraisal guidance no. 39 (available from: www.nice.org.uk/TA039) and additional support. The smoking status of those who are not ready to stop should be recorded and reviewed with the individual once a year, where possible.

Recommendation 4: Nurses in primary and community care should advise everyone who smokes* to stop and refer them to an intensive support service (for example, NHS Stop Smoking Services). If they are unwilling or unable to accept this referral they should be offered pharmacotherapy by practitioners with suitable training, in line with NICE technology appraisal guidance no. 39 (available from: www.nice.org.uk/TA039), and additional support. Nurses who are trained NHS stop smoking counsellors may "refer" to themselves where appropriate. The smoking status of those who are not ready to stop should be recorded and reviewed with the individual once a year, where possible.

Recommendation 5: All other health professionals, such as hospital clinicians, pharmacists, and dentists, should refer people who smoke* to an intensive support service (for example, NHS Stop Smoking Services). If the individual is unwilling or unable to accept this referral, practitioners with suitable training should offer a prescription of pharmacotherapy in line with NICE technology appraisal guidance no. 39 (available from: www.nice.org.uk/TA039), and additional support. Those who are trained NHS stop smoking counsellors may "refer" to themselves. Where possible, the smoking status of those who are not ready to stop should be recorded in clinical records and reviewed with the individual once a year, where possible.

Recommendation 6: Community workers*** should refer people who smoke* to an intensive support service (for example, NHS Stop Smoking Services). Those who are trained NHS stop smoking counsellors may "refer" to themselves.

*Occasionally it might be inappropriate to advise a patient to quit: for example, because of their presenting condition or personal circumstances.

**DiCLemente CC, Prochaska J, et al. (1991) The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology. Vol 59(2) 295-304.

***Community workers are practitioners working outside the health sector who have a remit for smoking cessation.

1.2.2 Strategic Recommendations for Policy Makers, Commissioners and Managers

Recommendation 7: Strategic health authorities, NHS hospital trusts, primary care trusts (PCTs), community pharmacies, local authorities, and local community groups should review smoking cessation policies and practices to take account of the recommendations in this guidance.

Recommendation 8: Smoking cessation advice and support should be available in community, primary, and secondary care settings for everyone who smokes. Local policy makers and commissioners should target hard to reach and deprived communities including minority ethnic groups, paying particular attention to their needs.

Recommendation 9: Monitoring systems should be set up to ensure health professionals have access to information on the current smoking status of their patients. This should include information on: a) the most recent occasion on which advice to stop was given, b) the nature of advice offered, and c) the response to that advice.

CLINICAL ALGORITHM(S)

A clinical algorithm on brief intervention for smokers is available in the original guideline document.

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type and quality of supporting evidence is identified and graded for each recommendation (see appendix A of the original guideline document).

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • National Institute for Health and Clinical Excellence (NICE). Brief interventions and referral for smoking cessation in primary care and other settings. London (UK): National Institute for Health and Clinical Excellence (NICE); 2006 Mar. 36 p. (Public health intervention; no. 1).

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2006 Mar

GUIDELINE DEVELOPER(S)

National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]

SOURCE(S) OF FUNDING

National Institute for Health and Clinical Excellence (NICE)

GUIDELINE COMMITTEE

NICE Project Team

Public Health Interventions Advisory Committee (PHIAC)

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

NICE Project Team Members: Mike Kelly, CPHE Director; Antony Morgan, Associate Director; Lesley Owen, Analyst; Patti White, Analyst; Bhash Naidoo, Health Economics Adviser

Public Health Interventions Advisory Committee (PHIAC) Members: Mrs Cheryll Adams, Professional Officer for Research and Practice, Development with the Community Practitioners' and Health Visitors' Association (CPHVA); Professor Ron Akehurst, Professor of Health Economics and Dean of the School of Health and Related Research (ScHARR), University of Sheffield; Professor Sue Atkinson, Regional Director of Public Health for London, Health Adviser to Mayor and Greater London Authority; Professor Michael Bury, Emeritus Professor of Sociology at the University of London and Honorary Professor of Sociology at the University of Kent; Professor Simon Capewell, Chair of Clinical Epidemiology, University of Liverpool; Professor K K Cheng, Professor of Epidemiology, University of Birmingham; Mr Philip Cutler, Forums Support Manager, Bradford Alliance on Community Care; Professor Brian Ferguson, Director of the Yorkshire and Humber Public Health Observatory; Dr Ruth Hall, Director of Public Health for Avon, Gloucestershire and Wiltshire Strategic Health Authority; Ms Amanda Hoey, Director, Consumer Health Consulting Limited; Mr Andrew Hopkin, Senior Assistant Director for Derby City Council; Dr Ann Hoskins, Director of Public Health for Cumbria and Lancashire Strategic Health Authority; Professor David R Jones, Professor of Medical Statistics in the Department of Health Sciences, University of Leicester; Dr Matt Kearney, General Practitioner, Castlefields, Runcorn, GP Public Health Practitioner, Knowsley; Ms Valerie King, Designated Nurse for Looked After Children for Northampton PCT, Daventry and South Northants PCT and Northampton General Hospital, Public Health Skills Development Nurse for Northampton PCT; Dr Catherine Law (Chair) Reader in Children's Health, Institute of Child Health, University College, London; Ms Sharon McAteer, Health Promotion Manager, Halton PCT; Professor Klim McPherson, Visiting Professor of Public Health Epidemiology, Department of Obstetrics and Gynaecology, University of Oxford; Professor Susan Michie, Professor of Health Psychology, BPS Centre for Outcomes Research & Effectiveness, University College, London; Ms Jane Putsey, Lay Representative, Chair of Trustees of the Breastfeeding Network for Cumbria and Lancashire Strategic Health Authority; Dr Mike Rayner, Director of British Heart Foundation Health Promotion Research Group, Department of Public Health, University of Oxford; Mr Dale Robinson, Chief Environmental Health Officer for South Cambridgeshire District Council; Professor Mark Sculpher, Professor of Health Economics at the Centre for Economics (CHE), University of York; Dr David Sloan, Director of Health Improvement & Public Health for City & Hackney Teaching PCT; Dr Michael Varnam, General Practitioner with the Community of Inner Nottingham; Dr Dagmar Zeuner, Consultant in Public Health with Islington PCT

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

All members of the Public Health Interventions Advisory Committee are required to make an oral declaration all potential conflicts of interest at the start of the consideration of each public health intervention appraisal. These declarations will be minuted and published on the National Institute for Health and Clinical Excellence (NICE) website.

Members are required to provide in writing an annual statement of current conflicts of interests, in accordance with the Institute's policy and procedures.

Potential members of the Public Health Programme Development Groups (PDG), and any individuals having direct input into the guidance (including expert peer reviewers), are required to provide a formal written declaration of personal interests. A standard form has been developed for this purpose which also includes the Institute's standard policy for declaring interests. This declaration of interest form should be completed before any decision about the involvement of an individual is taken.

Any changes to a Group member's declared conflicts of interests should also be recorded at the start of each PDG meeting. The PDG Chair should determine whether these interests are significant.  If a member of the PDG has a possible conflict of interest with only a limited part of the guidance development or recommendations, that member may continue to be involved in the overall process but should withdraw from involvement in the area of possible conflict. This action should be documented and be open to external review. If it is considered that an interest is significant in that it could impair the individual's objectivity throughout the development of public health guidance, he or she should not be invited to join the group.

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

The following are available:

Print copies: Available from the National Health Service (NHS) Response Line 0870 1555 455. ref: N1014. 11 Strand, London, WC2N 5HR.

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on October 23, 2006. The information was verified by the guideline developer on February 6, 2007.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo